These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35417274)

  • 21. [Retrospective investigation of anti-VEGF treatment reality and effectiveness in patients with neovascular age-related macular degeneration (AMD) in Germany: treatment reality of ranibizumab for neovascular AMD in Germany].
    Ziemssen F; Eter N; Fauser S; Bopp S; Radermacher M; Hasanbasic Z; Holz FG;
    Ophthalmologe; 2015 Mar; 112(3):246-54. PubMed ID: 25668709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation studies of ranibizumab for neovascular age-related macular degeneration.
    Bloch SB
    Acta Ophthalmol; 2013 Nov; 91 Thesis7():1-22. PubMed ID: 24206851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration.
    Cruess AF; Berger A; Colleaux K; Greve M; Harvey P; Kertes PJ; Sheidow T; Tourville E; Williams G; Wong D
    Can J Ophthalmol; 2012 Jun; 47(3):227-35. PubMed ID: 22687297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography.
    Manjunath V; Goren J; Fujimoto JG; Duker JS
    Am J Ophthalmol; 2011 Oct; 152(4):663-8. PubMed ID: 21708378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aflibercept for neovascular age-related macular degeneration.
    Sarwar S; Clearfield E; Soliman MK; Sadiq MA; Baldwin AJ; Hanout M; Agarwal A; Sepah YJ; Do DV; Nguyen QD
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011346. PubMed ID: 26857947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration.
    Beck M; Munk MR; Ebneter A; Wolf S; Zinkernagel MS
    Am J Ophthalmol; 2016 Jul; 167():10-7. PubMed ID: 27084000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic Review.
    Okada M; Mitchell P; Finger RP; Eldem B; Talks SJ; Hirst C; Paladini L; Barratt J; Wong TY; Loewenstein A
    Ophthalmology; 2021 Feb; 128(2):234-247. PubMed ID: 32763265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient characteristics and treatment of neovascular age-related macular degeneration in France: the LUEUR1 observational study.
    Cohen SY; Souied EH; Weber M; Dupeyron G; de Pouvourville G; Lievre M; Ponthieux A
    Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):521-7. PubMed ID: 21057805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents.
    Gemenetzi M; Lotery AJ; Patel PJ
    Eye (Lond); 2017 Jan; 31(1):1-9. PubMed ID: 27716750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Patient-Reported Outcomes and Time to Late Age-Related Macular Degeneration in the Laser Intervention in Early Stages of Age-Related Macular Degeneration Study.
    McGuinness MB; Finger RP; Wu Z; Luu CD; Chen FK; Arnold JJ; Chakravarthy U; Guymer RH;
    Ophthalmol Retina; 2020 Sep; 4(9):881-888. PubMed ID: 32418845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration.
    Finger RP; Guymer RH; Gillies MC; Keeffe JE
    Ophthalmology; 2014 Jun; 121(6):1246-51. PubMed ID: 24518613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration.
    Scott AW; Bressler SB
    Curr Opin Ophthalmol; 2013 May; 24(3):190-6. PubMed ID: 23492430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration.
    Muether PS; Neuhann I; Buhl C; Hermann MM; Kirchhof B; Fauser S
    Retina; 2013 Oct; 33(9):1809-14. PubMed ID: 23492946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cataract surgery in patients with neovascular age-related macular degeneration.
    Kessel L; Koefoed Theil P; Lykke Sørensen T; Munch IC
    Acta Ophthalmol; 2016 Dec; 94(8):755-760. PubMed ID: 27255691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
    Feng L; Hu JH; Chen J; Xie X
    J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
    Krishnan R; Arora R; De Salvo G; Stinghe A; Severn PS; Pal B; Goverdhan S
    Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration.
    Abdolrahimzadeh S; Gharbiya M; Formisano M; Bertini F; Cerini A; Pacella E
    Curr Eye Res; 2019 Sep; 44(9):1000-1005. PubMed ID: 30999772
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review.
    Waugh N; Loveman E; Colquitt J; Royle P; Yeong JL; Hoad G; Lois N
    Health Technol Assess; 2018 May; 22(27):1-168. PubMed ID: 29846169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
    Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.